UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Virgin Galactic
SPCE
$398M
| $1.12M | ﹤0.01% |
+3,439
| New | +$1.13M |
|
|
SWAV
1702
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.12M | ﹤0.01% |
23,569
+15,069
| +177% | +$621K |
|
|
SYKE
1703
DELISTED
SYKES Enterprises Inc
SYKE
| $1.12M | ﹤0.01% |
40,354
+3,727
| +10% | +$101K |
|
1704
Upwork
UPWK
$1.19B
| $1.11M | ﹤0.01% |
77,158
-677
| -0.9% | -$7.11K |
|
1705
Fortis
FTS
$28.7B
| $1.11M | ﹤0.01% |
29,237
-7,071
| -19% | -$270K |
|
1706
Kaiser Aluminum
KALU
$3.02B
| $1.11M | ﹤0.01% |
15,121
-2,900
| -16% | -$207K |
|
1707
James River Group Holdings
JRVR
$217M
| $1.11M | ﹤0.01% |
24,736
-151
| -0.6% | -$5.61K |
|
|
EPZM
1708
DELISTED
Epizyme, Inc
EPZM
| $1.11M | ﹤0.01% |
68,961
+4,644
| +7% | +$81.1K |
|
1709
Stride
LRN
$3.43B
| $1.1M | ﹤0.01% |
40,471
+2,117
| +6% | +$50.9K |
|
|
INOV
1710
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.1M | ﹤0.01% |
57,173
-5,753
| -9% | -$102K |
|
1711
Veracyte
VCYT
$3.8B
| $1.09M | ﹤0.01% |
42,256
-2,973
| -7% | -$74.1K |
|
1712
Nelnet
NNI
$4.7B
| $1.09M | ﹤0.01% |
22,912
-7,759
| -25% | -$363K |
|
|
FBC
1713
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $1.09M | ﹤0.01% |
37,132
-687
| -2% | -$17.6K |
|
1714
Sinclair Inc
SBGI
$1.03B
| $1.09M | ﹤0.01% |
59,164
-61,345
| -51% | -$1.06M |
|
1715
Banner Corp
BANR
$2.4B
| $1.09M | ﹤0.01% |
28,732
-8,006
| -22% | -$285K |
|
|
VIVO
1716
DELISTED
Meridian Bioscience Inc
VIVO
| $1.09M | ﹤0.01% |
46,776
-2,864
| -6% | -$41.5K |
|
1717
Middlesex Water
MSEX
$1.1B
| $1.09M | ﹤0.01% |
16,213
-1,351
| -8% | -$85.6K |
|
1718
Methode Electronics
MEI
$592M
| $1.09M | ﹤0.01% |
34,825
-10,703
| -24% | -$321K |
|
1719
Terex
TEX
$7.74B
| $1.09M | ﹤0.01% |
57,893
-38,248
| -40% | -$609K |
|
1720
Patterson-UTI
PTEN
$3.76B
| $1.09M | ﹤0.01% |
312,783
-55,654
| -15% | -$192K |
|
1721
Medifast
MED
$141M
| $1.08M | ﹤0.01% |
7,792
-2,240
| -22% | -$206K |
|
1722
NMI Holdings
NMIH
$3.36B
| $1.08M | ﹤0.01% |
67,242
-23,547
| -26% | -$335K |
|
|
RCM
1723
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.08M | ﹤0.01% |
96,929
+10,937
| +13% | +$113K |
|
1724
Kosmos Energy
KOS
$1.48B
| $1.08M | ﹤0.01% |
649,528
+148,628
| +30% | +$239K |
|
|
BFS
1725
Saul Centers
BFS
$841M
| $1.08M | ﹤0.01% |
33,382
-1,139
| -3% | -$36.3K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.